Evogene raises $74 million in NYSE debut

00:07 AM | November 25, 2013

Shares of Evogene (Rehovot, Israel), a plant genomics firm in which both Monsanto and Bayer hold significant stakes, debuted 21 November on the New York Stock Exchange at $14.75/share. The initial...